Nasenspray-Ratiopharm® Kinder (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride works as a selective alpha‑adrenergic agonist. When sprayed into the nose, it binds to alpha‑1 receptors on the blood vessels of the nasal mucosa, causing vasoconstriction. This reduces blood flow, decreases mucosal edema, and opens the nasal airway, providing rapid decongestion.

The exact dosing regimen for Nasenspray‑Ratiopharm® Kinder is determined by the prescribing healthcare professional. Typically, the prescriber will advise the number of sprays per nostril and the maximum duration of use, which should not exceed the recommended limit to avoid rebound congestion.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. Women who are pregnant or breastfeeding should discuss potential risks and benefits with their physician before using this nasal spray, as the prescriber may recommend alternative treatments.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials. The team then provides pricing, availability, shipping details, and any necessary import documentation.

Nasenspray‑Ratiopharm® Kinder uses Xylometazoline, an imidazoline‑type decongestant, which provides rapid relief with a relatively low systemic absorption compared with phenylephrine or pseudoephedrine. It is formulated for pediatric use, whereas some alternatives are not approved for children or have a higher risk of systemic side effects.

Store Nasenspray‑Ratiopharm® Kinder at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keep the cap tightly closed when not in use to maintain product integrity and prevent accidental exposure.

The spray is applied directly into each nostril as directed by a healthcare professional. The user gently inserts the nozzle into the nostril, presses the pump to deliver the prescribed number of sprays, and then repeats in the other nostril if instructed. No swallowing is required.

Serious risks include rebound nasal congestion if used longer than recommended, severe hypertension, cardiac arrhythmias, and rare allergic reactions such as rash or swelling. Persistent nasal irritation or ulceration also warrants immediate medical attention.

Children under 2 years of age, individuals with known hypersensitivity to Xylometazoline or any component of the formulation, and patients with severe hypertension, coronary artery disease, or uncontrolled cardiac conditions should avoid using this product unless advised otherwise by a physician.